Q. Li et al. / Bioorg. Med. Chem. Lett. 16 (2006) 2428–2432
2431
2H), 1.57 (m, 2H), 1.39–1.11 (m, 18H), 0.82–0.92 (t, 3H);
13C NMR (CDCl3) d: 146.45, 145.76, 133.63, 132.72,
129.62, 129.54, 114.95, 113.16, 69.83, 69.12, 58.53, 56.43,
47.49, 47.05, 35.10, 35.04, 32.17, 32.03, 31.97, 29.93, 29.88,
29.80, 29.60, 22.94, 14.38.
Synthesis of 2c: epichlorohydrin 8.33 g (7.1 ml, 90 mmol)
was added dropwise to the solution of hexylamine 3 g (4 ml,
30 mmol) in ethanol (30 ml) at 5 ꢁC over 15 min. The
mixture was stirred at room temperature for 8 h and the
solvent was removed by vacuum desiccation. A transparent
and viscous liquid was obtained, which was further purified
by flash chromatography using hexanes/ethyl acetate (3:1,
Rf = 0.57) as the eluent to give the final product (12.5 g). 1H
NMR (CDCl3) d 0.845 (t, 3H), 1.215 (m, 6H), 1.416 (m, 2H),
2.493–2.72 (m, 6H), 2.95–3.41 (br s, 1H), 3.49–3.58 (m, 4H),
3.84–3.88 (m, 2H).
and characterized by NMR. Under our experimental
conditions, the number-average molecular weights
(Mn) of the compounds ranged from 1396 to 2072,
and the weight-average molecular weights (Mw) ranged
from 1783 to 2736. Biological tests in BL6 cells revealed
excellent but variable biological activities in gene deliv-
ery, depending on the backbone structure and the chain
length of the hydrophobic moiety. The detailed investi-
gations on structure–activity relation of these com-
pounds in vivo are in progress.
Acknowledgments
We thank Professor David Edwards for proofreading
of the manuscript. This work was supported in part by
the National Institutes of Health (R01-HL075542).
Synthesis of 2d: mixture of epichlorohydrin (10 g,
108 mmol) and octadecylamine (7 g, 25 mmol) in 30 ml
isopropyl ether and 60 ml ethanol was stirred at room
temperature overnight and concentrated under reduced
pressure. The crude product was isolated by chromatogra-
phy on a silica gel column with chloroform/methanol (14:1
v/v, Rf = 0.65) as the eluent to afford a white solid of 9.1 g.
1H NMR (CDCl3) d 3.91–3.86 (m, 2H), 3.61–3.50 (m, 4H),
3.49–3.18 (br s, 2H), 2.75–2.51 (m, 6H), 1.45 (br s, 2H), 1.24
(br s, 30H), 0.87 (t, 3H); 13C NMR (CDCl3) d: 69.30, 68.75,
58.89, 58.34, 56.13, 56.10, 47.64, 47.50, 32.15, 29.92, 29.88,
29.84, 29.76, 29.59, 27.51, 27.16, 27.09, 22.92, 14.34.
Synthesis of 2e: to 13 ml of ethanol epichlorohydrine
(13.1 g, 0.141 mmol) was added dropwise methylamine
(33% wt solution in absolute ethanol, 0.645 mmol) at ꢀ5 ꢁC.
The mixture was stirred at rt for 6 h and then at 4 ꢁC
overnight. The reaction mixture was then concentrated
under vacuum to afford the product as a colorless and
References and notes
1. Hirko, A.; Tang, F.; Hughes, J. A. Curr. Med. Chem.
2003, 10, 1185.
2. Ewert, K.; Slack, N. L.; Ahmad, A.; Evans, H. M.; Lin, A.
J.; Samuel, C. E.; Safinya, C. R. Curr. Med. Chem. 2004,
77, 133.
3. Liu, D.; Ren, T.; Gao, X. Curr. Med. Chem. 2003, 70,
1307.
4. Merdan, T.; Kopecek, J.; Kissel, T. Adv. Drug Deliv. Rev.
2002, 54, 715.
5. Kubasiak, L. A.; Tomalia, D. A. In Polymeric Gene
Delivery: Principles and Applications; Mansoor, M. A.,
Amiji, E., Eds.; CRC Press: Boca Raton, USA, 2005;
pp 133–157.
6. Haensler, J.; Szoka, F. C., Jr. Bioconjugate Chem. 1993, 4,
372.
7. Tang, M. X.; Redemann, C. T.; Szoka, F. C., Jr.
Bioconjugate Chem. 1996, 7, 703.
8. Li, Y.; Wang, J.; Lee, C. G.; Wang, C.; Gao, S. J.; Tang,
G. P.; Ma, Y. X.; Yu, H.; Mao, H. Q.; Leong, K. W.;
Wang, S. Gene Ther. 2004, 77, 109.
9. Kim, Y. H.; Park, J. H.; Lee, M.; Kim, Y. H.; Park, T. G.;
Kim, S. W. J. Controlled Release 2005, 103, 209.
10. Preparation of monomers. Synthesis of monomer 2a:
epichlorohydrin (3.9 ml, 50 mmol) was added to a solution
of dodecylamine (4.63 g, 25 mmol) in ethanol (13 ml) at
room temperature. The mixture was stirred for overnight
and the solvent was evaporated under vacuum. The crude
product was purified by flash chromatography on a silica
gel column with chloroform/methanol (14:1) as the eluent
to yield 2a as a white solid (8 g). 1H NMR (CDCl3) d:
0.861 (t, 3 H), 1.26 (single, 18H), 1.37–1.52 (brand, 2H),
2.74–2.51 (m, 6H), 3.25–3.48 (br s, 2H), 3.50–3.60 (m, 4H),
3.85–3.90 (m, 2H); 13C NMR (CDCl3) d: 69.30, 68.76,
58.87, 58.31, 56.12, 56.10, 47.64, 47.51, 32.13, 29.87, 29.85,
29.83, 29.76, 29.56, 27.51, 27.19, 27.13, 22.91, 14.34.
Synthesis of monomer 2b: mixture of epichlorohydrin
(1.16 g, 12.5 mmol), dodecylaniline (1.31 g, 5 mmol), and
ethanol (l ml) was stirred at room temperature for 18 h. A
white solid after removal of solvent under vacuum was
obtained and purified by flash chromatography using a
chloroform/isopropyl ether (10:0.7) eluent (Rf = 0.38),
resulting in 2.03 g white solid. The NMR results indicate
that this compound exists in two isomers. 1H NMR
(CDCl3) d: 7.08–7.05 (quat, 2H), 6.79–6.77 (d, 1H), 6.64
(d, 1H), 4.20–4.11 (m, 2H), 3.88 (d, 1H), 3.68–3.48 (m,
5H), 3.41–3.36 (m, 2H), 3.18–3.08 (m, 1H), 2.53–2.49 (m,
1
viscous liquid (96%). H NMR (CD3CN) d 2.28 (d, 3H),
2.41–2.56 (m, 4H), 3.51–3.57 (m, 2H), 3.61–3.66 (2H), 3.82–
3.89 (m, 2H).
11. Preparation of lipopolyhydroxylalkyleneamines: com-
pounds 3a–3f were synthesized by condensation of bis(2-
hydroxy-3-chloropropyl)alkylamine and ethylenediamine
(EDA) in 1-butanol/water (2:1) at around 95 ꢁC for 24–48 h
(compounds 3a–3d); or bis(2-hydroxy-3-chloropropyl)-
alkylamine and tetramethylenediamine in butanol/water
(1:1) with reflux overnight (compounds 3e, 3f). The reaction
mixture was concentrated under reduced pressure. After
washing with chloroform, acetone, and cooled methanol
to remove unreacted monomers and low molecular
weight oligomers, a crystalline amorphous solid was
obtained.
Compound 3a: 1H NMR (CD3OD) d 0.80 (t, 3H), 1.15–1.40
(br s 18H), 1.40–1.70 (br s 2H), 2.45–3.16 (br s, 14H), 3.82–
4.17 (br s, 2H).
Compound 3b: (D2O + DMSO) 1H NMR (D2O) d 0.81 (br
s, 3H), 0.98–1.28 (br s, 18H), 1.30–1.45 (br s, 2H), 2.20–2.49
(m, 2H), 2.65–3.88 (br s, 12H), 4.20–4.11 (m, 2H), 6.71 (br s,
2H), 7.08–7.05 (br s, 2H).
Compound 3c: 1H NMR (D2O) d 0.87 (br s, 3H), 0.95–1.42
(br s, 8H), 2.1–3.15 (14H), 3.81–4.10 (br s, 2H).
Compound 3d: 1H NMR (D2O) d 0.82 (br s, 3H), 0.95–1.52
(br s, 36H), 2.1–3.15 (14H), 3.51–4.15 (br s, 2H).
Compound 3e: 1H NMR (D2O) d 0.75–0.90 (br s, 3H), 1.15–
1.35 (br s, 18H), 1.38–1.52 (br s, 2H), 2.25–2.50 (br s, 6H),
2.60–2.8 (br s, 2H), 2.95–3.52 (m, 16H), 4.2–4.4 (br s,
2H).
1
Compound 3f: H NMR (D2O) d 0.85 (t, 3H), 1.24 (br s,
6H), 1.35–1.5 (br s, 2H), 2.48–2.65 (m, 6H), 2.74–2.95
(m, 2H), 3.10–3.65 (m, 18H), 3.95–4.35 (m, 2H).
Addition of monomer 2e to EDA/TMEDA/DMEDA
was accomplished using a 1:1 mixture of water/methanol